phrykt

Vivani Medical, Inc. (VANI): who owns it and who trades it

As of Nov 16, 2026, VANI insiders reported 17 purchases worth $16.7M in the last 12 months. The largest buyer was Gregg Williams (Director), with $16.7M. 2 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling Vivani Medical

From the latest filings

Overall: more buying than selling. Insiders and famous investors mostly bought.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Insider trades

In the last 12 months, VANI insiders reported $16.7M of open-market purchases and $0 of sales.

Purchases, 12 months
$16.7M
17 trades, 3 people
Sales, 12 months
$0
0 trades, 0 people
Sales under a 10b5-1 plan
–
Share of sale value
Latest trade
Nov 13, 2026
Filed Nov 16, 2026

Purchases and sales by month

$4M$4MDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Nov 13, 2026Gregg WilliamsDirectorPurchase48,100$0.99$47.8KForm 4
Nov 12, 2026Donald DwyerChief Business OfficerPurchase5,000$0.83$4.2KForm 4
Nov 12, 2026Donald DwyerChief Business OfficerPurchase15,000$1.03$15.5KForm 4
Jul 15, 2026Gregg WilliamsDirectorPurchase793,650$1.26$1000KForm 4
Jun 15, 2026Gregg WilliamsDirectorPurchase1.59M$1.26$2MForm 4
May 15, 2026Gregg WilliamsDirectorPurchase1.59M$1.26$2MForm 4
Apr 15, 2026Gregg WilliamsDirectorPurchase1.59M$1.26$2MForm 4
Mar 15, 2026Gregg WilliamsDirectorPurchase264,551$1.26$333KForm 4
Mar 15, 2026Gregg WilliamsDirectorPurchase1.31M$1.03$1.4MForm 4
Feb 15, 2026Gregg WilliamsDirectorPurchase264,551$1.26$333KForm 4
Feb 15, 2026Gregg WilliamsDirectorPurchase1.60M$1.03$1.6MForm 4
Jan 27, 2026Gregg WilliamsDirectorPurchase1.35M$1.48$2MForm 4
Jan 15, 2026Gregg WilliamsDirectorPurchase264,551$1.26$333KForm 4
Jan 15, 2026Gregg WilliamsDirectorPurchase1.47M$1.12$1.6MForm 4
Dec 29, 2025Aaron MendelsohnDirectorPurchase20,000$1.23$24.6KForm 4
Dec 15, 2025Gregg WilliamsDirectorPurchase1.47M$1.12$1.6MForm 4
Dec 15, 2025Gregg WilliamsDirectorPurchase264,551$1.26$333KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Gregg WilliamsDirector, 10% owner$16.7M–Nov 13, 2026
Aaron MendelsohnDirector$24.6K–Dec 29, 2025
Donald DwyerChief Business Officer$19.6K–Nov 12, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

VANI short interest

Low short interest. 0.4% of VANI shares are sold short: about 1 share in 244. Over the last 12 reports the number of shares short went down 6%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 369,789 VANI shares were sold short, 0.4% of the shares outstanding, down 11.4% from the report before. At the average daily volume of 181,963 shares, buying them all back would take about 2.0 trading days (days to cover).

Shares short, % of all shares

0.41%May 15Oct 300.83%

Days to cover

2.0May 15Oct 304.4

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 2026369,7890.41%-11%181,9632.0
Oct 15, 2026417,1480.46%-20%151,1592.8
Sep 30, 2026519,6870.58%-25%203,1502.6
Sep 15, 2026694,2660.77%+40%264,9922.6
Aug 31, 2026495,2360.55%-7%228,2322.2
Aug 14, 2026530,0900.59%+6%134,6393.9
Jul 31, 2026498,1740.59%+41%229,6202.2
Jul 15, 2026354,3700.42%-18%1.82M1.0
Jun 30, 2026432,6590.51%+14%186,2452.3
Jun 15, 2026379,1350.45%+13%145,2492.6
May 29, 2026335,9670.40%-14%234,0201.4
May 15, 2026392,6260.46%+12%170,7732.3

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

Vivani Medical company events

Vivani Medical filed 13 reports on Form 8-K in the last 12 months, 1 of them about an important change (leadership). The latest was on Oct 30, 2026.

  1. Oct 30, 2026AnnouncementShared information with investors. Filing
  2. Oct 29, 2026AnnouncementShared information with investors. Filing
  3. Sep 16, 2026AnnouncementShared information with investors. Filing
  4. Aug 17, 2026AnnouncementShared information with investors. Filing
  5. Aug 13, 2026ResultsReleased financial results. Filing
  6. Aug 6, 2026AnnouncementShared information with investors. Filing
  7. Jul 16, 2026AnnouncementShared information with investors. Filing
  8. Jul 7, 2026AgreementVivani Medical, Inc. entered into a definitive agreement and plan of merger among its wholly owned subsidiary Cortigent, Inc., ClearOne, Inc., a Nasdaq-listed Nevada company, and CLRO Merger Sub, Inc. a Delaware corporation wholly owned subsidiary of ClearOne, pursuant to which Cortigent will merge… Filing
  9. Jun 30, 2026LeadershipThe board of directors, of Vivani Medical, Inc., adopted and approved, subject to stockholder approval, an amendment and restatement of the Vivani Medical, Inc. 2022 Omnibus Incentive Plan, (the “2022 Plan”, as so amended and restated, the “2022 Amended Plan”), all as described in Vivani’s… Filing
  10. Jun 4, 2026AnnouncementShared information with investors. Filing
  11. May 13, 2026ResultsReleased financial results. Filing
  12. Mar 26, 2026ResultsReleased financial results. Filing
  13. Jan 27, 2026AgreementPrivate Placement Vivani Medical, Inc. entered into a Share Purchase Agreement, dated January 25, 2026, with an entity affiliated with Gregg Williams, Chairman of the Company’s board of directors for the purchase of an aggregate of 1,351,351 shares of common stock, par value of $0.0001 per share of… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

Vivani Medical financials

Famous investors that hold VANI

2 of the 50 well-known investors we track reported holding VANI in their latest 13F filing. The largest position is Israel Englander's, worth $87.7K.

FundQuarterSharesValueOf portfolioChange
Israel Englander · Millennium ManagementQ3 202670,730$87.7K0.0%New
Ken Griffin · Citadel AdvisorsQ3 202654,758$67.9K0.0%New

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

Questions about Vivani Medical, Inc. (VANI) stock

Are VANI insiders buying or selling?

In the last 12 months, VANI insiders reported 17 open-market purchases worth $16.7M and no sales. The latest trade was on Nov 13, 2026. See every trade.

What is the short interest in VANI?

As of Oct 30, 2026, 369,789 VANI shares were sold short, 0.4% of the shares outstanding, down 11.4% from the report before. At the average daily volume of 181,963 shares, buying them all back would take about 2.0 trading days (days to cover). See the history.

Which famous investors hold VANI?

2 of the 50 well-known investors we track reported VANI in their latest 13F filing, including Israel Englander, Ken Griffin. The largest position is worth $87.7K. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.